Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study Evaluating the Feasibility of Memantine in Reducing Cognitive Impairment in Pediatric Patients After Radiation Therapy for Central Nervous System Tumors

NCT04217694 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT04217694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04217694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study Evaluating the Feasibility of Memantine in Reducing Cognitive Impairment in Pediatric Patients After Radiation Therapy for Central Nervous System Tumors
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
February 17, 2020
Completion date
August 12, 2024
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant central nervous system neoplasm, primary central nervous system neoplasm